Examining Anti-VEGF Biosimilars in the Management of Retinal Diseases
home / case-based-roundtable-series / examining-anti-vegf-biosimilars-in-the-management-of-retinal-diseases
Dilsher S. Dhoot, MD shares his experience leading a case-based roundtable discussion on anti-VEGF biosimilars for retinal diseases, highlighting key insights from each patient case.
